Sy Co., Ltd. (KOSDAQ:109610)
South Korea · Delayed Price · Currency is KRW 3,335.00
-35.00 (-1.04%)
At close: Aug 4, 2025, 3:30 PM KST
Ligand Pharmaceuticals Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Other Revenue | - | - | - | - | -0 | 0 | Upgrade |
| 539,329 | 561,009 | 553,670 | 537,202 | 424,098 | 310,073 | Upgrade | |
Revenue Growth (YoY) | -5.21% | 1.32% | 3.06% | 26.67% | 36.77% | -18.43% | Upgrade |
Cost of Revenue | 482,408 | 494,406 | 490,901 | 483,104 | 377,109 | 290,314 | Upgrade |
Gross Profit | 56,921 | 66,603 | 62,770 | 54,098 | 46,988 | 19,759 | Upgrade |
Selling, General & Admin | 41,798 | 41,293 | 39,074 | 32,364 | 26,816 | 25,833 | Upgrade |
Research & Development | 194.59 | 146.12 | 51.2 | 229 | 115.68 | 159.27 | Upgrade |
Other Operating Expenses | 1,278 | 1,394 | 1,272 | 1,298 | 889.34 | 1,114 | Upgrade |
Operating Expenses | 43,171 | 44,668 | 50,339 | 39,287 | 32,878 | 32,222 | Upgrade |
Operating Income | 13,750 | 21,935 | 12,431 | 14,811 | 14,110 | -12,464 | Upgrade |
Interest Expense | -8,487 | -8,538 | -8,494 | -6,140 | -4,884 | -8,693 | Upgrade |
Interest & Investment Income | 259.99 | 276.64 | 422.64 | 166.48 | 347.58 | 601.82 | Upgrade |
Earnings From Equity Investments | -322.31 | -322.31 | -496.1 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -1,519 | -1,519 | -266.55 | 1,109 | 1,790 | -1,665 | Upgrade |
Other Non Operating Income (Expenses) | 1,839 | 1,017 | -442.36 | 259.96 | 1,386 | -8,337 | Upgrade |
EBT Excluding Unusual Items | 5,521 | 12,850 | 3,154 | 10,207 | 12,749 | -30,557 | Upgrade |
Gain (Loss) on Sale of Investments | 109.44 | 109.44 | 185.39 | 116.12 | 1,306 | -385.93 | Upgrade |
Gain (Loss) on Sale of Assets | 854.35 | 590.48 | 754.38 | 38.89 | 173.66 | 2,096 | Upgrade |
Asset Writedown | -84.23 | -84.23 | -7,790 | 2,018 | -3,997 | -744.79 | Upgrade |
Pretax Income | 6,400 | 13,466 | -3,696 | 12,379 | 10,232 | -29,591 | Upgrade |
Income Tax Expense | 5,948 | 7,144 | 5,841 | 4,332 | 1,214 | -542.53 | Upgrade |
Earnings From Continuing Operations | 452.29 | 6,321 | -9,536 | 8,048 | 9,018 | -29,049 | Upgrade |
Net Income to Company | 452.29 | 6,321 | -9,536 | 8,048 | 9,018 | -29,049 | Upgrade |
Minority Interest in Earnings | -2,197 | -2,887 | 504.79 | 53.41 | -183.58 | 4,558 | Upgrade |
Net Income | -1,745 | 3,434 | -9,032 | 8,101 | 8,835 | -24,491 | Upgrade |
Net Income to Common | -1,745 | 3,434 | -9,032 | 8,101 | 8,835 | -24,491 | Upgrade |
Net Income Growth | - | - | - | -8.30% | - | - | Upgrade |
Shares Outstanding (Basic) | 47 | 47 | 48 | 48 | 46 | 28 | Upgrade |
Shares Outstanding (Diluted) | 47 | 47 | 48 | 48 | 48 | 28 | Upgrade |
Shares Change (YoY) | -1.97% | -1.44% | - | -0.63% | 70.96% | 0.27% | Upgrade |
EPS (Basic) | -37.08 | 72.99 | -189.19 | 169.70 | 192.97 | -871.51 | Upgrade |
EPS (Diluted) | -37.08 | 72.99 | -200.00 | 169.70 | 183.90 | -871.51 | Upgrade |
EPS Growth | - | - | - | -7.72% | - | - | Upgrade |
Free Cash Flow | -26,135 | -13,302 | -13,115 | 11,430 | -26,531 | -896.38 | Upgrade |
Free Cash Flow Per Share | -555.47 | -282.72 | -274.74 | 239.43 | -552.25 | -31.90 | Upgrade |
Gross Margin | 10.55% | 11.87% | 11.34% | 10.07% | 11.08% | 6.37% | Upgrade |
Operating Margin | 2.55% | 3.91% | 2.25% | 2.76% | 3.33% | -4.02% | Upgrade |
Profit Margin | -0.32% | 0.61% | -1.63% | 1.51% | 2.08% | -7.90% | Upgrade |
Free Cash Flow Margin | -4.85% | -2.37% | -2.37% | 2.13% | -6.26% | -0.29% | Upgrade |
EBITDA | 24,997 | 33,229 | 24,862 | 27,854 | 27,502 | -15.67 | Upgrade |
EBITDA Margin | 4.63% | 5.92% | 4.49% | 5.18% | 6.49% | -0.01% | Upgrade |
D&A For EBITDA | 11,247 | 11,294 | 12,431 | 13,042 | 13,392 | 12,448 | Upgrade |
EBIT | 13,750 | 21,935 | 12,431 | 14,811 | 14,110 | -12,464 | Upgrade |
EBIT Margin | 2.55% | 3.91% | 2.25% | 2.76% | 3.33% | -4.02% | Upgrade |
Effective Tax Rate | 92.93% | 53.06% | - | 34.99% | 11.86% | - | Upgrade |
Advertising Expenses | - | 1,562 | 1,630 | 372.63 | 266.4 | 271.04 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.